HCW Biologics, a Shareholder of Wugen, Congratulates Wugen on Its Recent Successful Equity Financing
Provided By GlobeNewswire
Last update: Sep 18, 2025
Wugen closed a $115 million equity financing led by
Fidelity Management & Research Company
HCW Biologics holds a minority equity interest in Wugen
Read more at globenewswire.comNASDAQ:HCWB (10/20/2025, 3:35:21 PM)
3.95
-0.04 (-1%)
Find more stocks in the Stock Screener
